Medical Weight Loss for Maplewood, Minnesota Residents

Maplewood, Minnesota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Maplewood through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for Maplewood residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your Minnesota telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why Maplewood Residents Choose New Hope Weight Loss

For Maplewood patients who want a doctor genuinely involved, this is the right fit. Compounded semaglutide and tirzepatide are powerful tools, but they are not for everyone, and Dr. Anjmun Sharma treats them that way. She looks at your labs, your medications, and your goals before anything is prescribed, then keeps adjusting as your body responds. These medications are not FDA-approved and results vary, which is exactly why physician oversight matters this much.

Medical weight loss for Maplewood is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

The care you would find at our Costa Mesa clinic follows you home to Maplewood through telehealth, giving Minnesota patients the same physician oversight without a single mile of travel. We care for patients throughout Maplewood and the eastern St. Paul metro of Ramsey County. A licensed care coordinator stays reachable by message and phone, so help is a few taps away anywhere in Minnesota.

There are no local-office hours to fit your life around, so Maplewood patients can meet Dr. Sharma on evenings or between work without crossing town. Getting started in Maplewood is simple: a Minnesota licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. Wherever you live in Minnesota, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic, with no travel required.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Maplewood patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Maplewood

Here is how the whole thing works, start to finish, for anyone in Maplewood.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Maplewood address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Maplewood

Does New Hope Weight Loss actually serve Maplewood, or only Costa Mesa?

We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Maplewood, Minnesota through telehealth. Residents across neighborhoods like Maplewood and the eastern St. Paul metro of Ramsey County qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.

Can the whole process be done remotely from Maplewood?

Yes, it is fully remote. There is no in-person requirement for Maplewood patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.

How much will a Maplewood patient pay?

Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Maplewood residents pay no added distance fee.

What areas of Maplewood do you serve?

We serve patients from across Maplewood by telehealth, including Maplewood and the eastern St. Paul metro of Ramsey County.

How is medication shipped to Maplewood patients?

After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Maplewood address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.

Maplewood Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Maplewood, Minnesota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.